Hankey G J, Slattery J M, Warlow C P
Department of Clinical Neurosciences, Western General Hospital, Edinburgh.
BMJ. 1991 Mar 2;302(6775):499-504. doi: 10.1136/bmj.302.6775.499.
To determine the prognosis and adverse prognostic factors in patients with retinal infarction due to presumed atheromatous thromboembolism or cardiogenic embolism.
Prospective cohort study.
University hospital departments of clinical neurology.
99 patients with retinal infarction, without prior stroke, referred to a single neurologist between 1976 and 1986 and evaluated and followed up prospectively until death or the end of 1986 (mean follow up 4.2 years).
Cerebral angiography (55 patients), aspirin treatment (37), oral anticoagulant treatment (eight), carotid endarterectomy (13), cardiac surgery (six), and peripheral vascular surgery (two).
Death, stroke, coronary events, contralateral retinal infarction; survival analysis confined to 98 patients with retinal infarction due to presumed artheromatous thromboembolism or cardiogenic embolism (one patient with giant cell arteries excluded), and Cox's proportional hazards regression analysis, including age as a prognostic factor.
During follow up 29 patients died (21 of vascular causes and eight of non-vascular or unknown causes), 10 had a first ever stroke, 19 had a coronary event, and only one developed contralateral retinal infarction. A coronary event accounted for more than half (59%) of the deaths whereas stroke was the cause of only one death (3%). Over the first five years after retinal infarction the actuarial average absolute risk of death was 8% per year; of stroke 2.5% per year (7.4% in the first year); of coronary events 5.3% per year, exceeding that of stroke; and of stroke, myocardial infarction, or vascular death 7.4% per year. Prognostic factors associated with an increased risk of death were increasing age, peripheral vascular disease, cardiomegaly, and carotid bruit. Adverse prognostic factors for serious vascular events were increasing age and carotid bruit for stroke, and increasing age, cardiomegaly, and carotid bruit both for coronary events and for stroke, myocardial infarction, or vascular death.
Patients who present with retinal infarction due to presumed atherothromboembolism or cardiogenic embolism are at considerable risk of a coronary event. The risk of stroke, although high, is not so great. Not all strokes occurring after retinal infarction relate directly to disease of the ipsilateral carotid system, although this is probably the most common cause. Few patients experience contralateral retinal infarction. Non-arteritic retinal infarction should be diagnosed or confirmed by an ophthalmologist, and the long term care of patients with the condition should involve a physician who has an active interest in managing vascular disease.
确定因疑似动脉粥样硬化性血栓栓塞或心源性栓塞导致视网膜梗死患者的预后及不良预后因素。
前瞻性队列研究。
大学医院临床神经科。
99例视网膜梗死患者,既往无卒中史,于1976年至1986年间转诊至同一位神经科医生处,进行前瞻性评估及随访,直至死亡或1986年底(平均随访4.2年)。
脑血管造影(55例患者)、阿司匹林治疗(37例)、口服抗凝治疗(8例)、颈动脉内膜切除术(13例)、心脏手术(6例)及外周血管手术(2例)。
死亡、卒中、冠状动脉事件、对侧视网膜梗死;生存分析仅限于98例因疑似动脉粥样硬化性血栓栓塞或心源性栓塞导致视网膜梗死的患者(1例巨细胞动脉炎患者除外),以及Cox比例风险回归分析,将年龄作为预后因素。
随访期间,29例患者死亡(21例死于血管性原因,8例死于非血管性或不明原因),10例首次发生卒中,19例发生冠状动脉事件,仅1例发生对侧视网膜梗死。冠状动脉事件占死亡病例的一半以上(59%),而卒中仅导致1例死亡(3%)。视网膜梗死后的前五年,精算平均每年绝对死亡风险为8%;卒中为每年2.5%(第一年为7.4%);冠状动脉事件为每年5.3%,超过卒中风险;卒中合并心肌梗死或血管性死亡为每年7.4%。与死亡风险增加相关的预后因素为年龄增长、外周血管疾病、心脏扩大及颈动脉杂音。严重血管事件的不良预后因素为年龄增长及颈动脉杂音(卒中),年龄增长、心脏扩大及颈动脉杂音(冠状动脉事件及卒中、心肌梗死或血管性死亡)。
因疑似动脉粥样硬化性血栓栓塞或心源性栓塞导致视网膜梗死的患者发生冠状动脉事件的风险相当高。卒中风险虽高,但并非如此严重。视网膜梗死后发生的所有卒中并非都直接与同侧颈动脉系统疾病相关,尽管这可能是最常见的原因。很少有患者发生对侧视网膜梗死。非动脉炎性视网膜梗死应由眼科医生诊断或确诊,对该疾病患者的长期护理应由积极关注血管疾病管理的医生负责。